Dermatomyositis as a presentation of neuromyelitis optica spectrum disorder

被引:11
作者
Delman, David [1 ]
Peng, Xianming [1 ]
Zedek, Daniel C. [2 ]
Jewells, Valerie [3 ]
Chahin, Nizar [1 ]
Markovic-Plese, Silva [1 ,4 ]
机构
[1] Dept Neurol, Chapel Hill, NC 27599 USA
[2] Dept Dermatol, Chapel Hill, NC 27599 USA
[3] Dept Radiol, Chapel Hill, NC 27514 USA
[4] Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA
关键词
Neuromyelitis optica; Dermatomyositis; MDA5; antibody; INTERSTITIAL LUNG-DISEASE; MYOSITIS; AUTOANTIBODIES; INSIGHTS; CANCER;
D O I
10.1016/j.jneuroim.2014.07.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Importance: This is the first report of neuromyelitis optica spectrum disorder (NMOSD) associated with dermatomyositis (DM). Report: A 40 year-old Caucasian female presented with 6 months of worsening fatigue, rash, acute weakness worse in her lower extremities, and urinary retention. She was found to have both NMOSD and anti-melanoma differentiation-associated gene (MDA)5 positive DM with interstitial lung disease (ILD). She was treated aggressively and she regained her ability to ambulate. Conclusion: We recommend considering NMOSD in the differential diagnosis of patients with DM and other autoimmune disorders that also present with clinical signs of myelopathy. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:108 / 111
页数:4
相关论文
共 20 条
  • [1] Anti-MDA5 antibody is associated with A/SIP and decreased T cells in peripheral blood and predicts poor prognosis of ILD in Chinese patients with dermatomyositis
    Chen, Fang
    Wang, Dongxue
    Shu, Xiaoming
    Nakashima, Ran
    Wang, Guochun
    [J]. RHEUMATOLOGY INTERNATIONAL, 2012, 32 (12) : 3909 - 3915
  • [2] Ifih1 Gene Dose Effect Reveals MDA5-Mediated Chronic Type I IFN Gene Signature, Viral Resistance, and Accelerated Autoimmunity
    Crampton, Steve P.
    Deane, Jonathan A.
    Feigenbaum, Lionel
    Bolland, Silvia
    [J]. JOURNAL OF IMMUNOLOGY, 2012, 188 (03) : 1451 - 1459
  • [3] An open label study of the effects of rituximab in neuromyelitis optica
    Cree, BAC
    Lamb, S
    Morgan, K
    Chen, A
    Waubant, E
    Genain, C
    [J]. NEUROLOGY, 2005, 64 (07) : 1270 - 1272
  • [4] Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1γ
    Fiorentino, David F.
    Chung, Lorinda S.
    Christopher-Stine, Lisa
    Zaba, Lisa
    Li, Shufeng
    Mammen, Andrew L.
    Rosen, Antony
    Casciola-Rosen, Livia
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 (11): : 2954 - 2962
  • [5] Clinical and serological characteristics of 125 Dutch myositis patients - Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies
    Hengstman, GJD
    Brouwer, R
    Egberts, WTMV
    Seelig, HP
    Jongen, PJH
    van Venrooij, WJ
    van Engelen, BGM
    [J]. JOURNAL OF NEUROLOGY, 2002, 249 (01) : 69 - 75
  • [6] Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
    Jarius, Sven
    Ruprecht, Klemens
    Wildemann, Brigitte
    Kuempfel, Tania
    Ringelstein, Marius
    Geis, Christian
    Kleiter, Ingo
    Kleinschnitz, Christoph
    Berthele, Achim
    Brettschneider, Johannes
    Hellwig, Kerstin
    Hemmer, Bernhard
    Linker, Ralf A.
    Lauda, Florian
    Mayer, Christoph A.
    Tumani, Hayrettin
    Melms, Arthur
    Trebst, Corinna
    Stangel, Martin
    Marziniak, Martin
    Hoffmann, Frank
    Schippling, Sven
    Faiss, Juergen H.
    Neuhaus, Oliver
    Ettrich, Barbara
    Zentner, Christian
    Guthke, Kersten
    Hofstadt-van Oy, Ulrich
    Reuss, Reinhard
    Pellkofer, Hannah
    Ziemann, Ulf
    Kern, Peter
    Wandinger, Klaus P.
    Bergh, Florian Then
    Boettcher, Tobias
    Langel, Stefan
    Liebetrau, Martin
    Rommer, Paulus S.
    Niehaus, Sabine
    Muench, Christoph
    Winkelmann, Alexander
    Zettl U, Uwe K.
    Metz, Imke
    Veauthier, Christian
    Sieb, Joern P.
    Wilke, Christian
    Hartung, Hans P.
    Aktas, Orhan
    Paul, Friedemann
    [J]. JOURNAL OF NEUROINFLAMMATION, 2012, 9
  • [7] Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica
    Jiao, Yujuan
    Fryer, James P.
    Lennon, Vanda A.
    Jenkins, Sarah M.
    Quek, Amy M. L.
    Smith, Carin Y.
    McKeon, Andrew
    Costanzi, Chiara
    Iorio, Raffaele
    Weinshenker, Brian G.
    Wingerchuk, Dean M.
    Shuster, Elizabeth A.
    Lucchinetti, Claudia F.
    Pittock, Sean J.
    [J]. NEUROLOGY, 2013, 81 (14) : 1197 - 1204
  • [8] Myositis autoantibodies in Korean patients with inflammatory myositis: Anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis
    Kang, Eun Ha
    Nakashima, Ran
    Mimori, Tsuneyo
    Kim, Jinhyun
    Lee, Yun Jong
    Lee, Eun Bong
    Song, Yeong Wook
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2010, 11
  • [9] A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder
    Kim, Su-Hyun
    Huh, So-Young
    Lee, Sun Ju
    Joung, Aeran
    Kim, Ho Jin
    [J]. JAMA NEUROLOGY, 2013, 70 (09) : 1110 - 1117
  • [10] A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
    Lennon, VA
    Wingerchuk, DM
    Kryzer, TJ
    Pittock, SJ
    Lucchinetti, CF
    Fujihara, K
    Nakashima, I
    Weinshenker, BG
    [J]. LANCET, 2004, 364 (9451) : 2106 - 2112